Amgen (AMGN) is a publicly traded Healthcare sector company. As of September 5, 2026, AMGN trades at $414.75 with a market cap of $240.11B and a P/E ratio of 26.94. AMGN moved -1.57% today. Year to date, AMGN is +36.33%; over the trailing twelve months it is +54.15%. Its 52-week range spans $261.28 to $447.03. Analyst consensus is buy with an average price target of $396.29. Rallies surfaces AMGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest AMGN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $414.75 |
| Market Cap | $240.11B |
| P/E Ratio | 26.94 |
| EPS | $16.22 |
| Dividend Yield | 2.52% |
| 52-Week High | $447.03 |
| 52-Week Low | $261.28 |
| Volume | 982.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $38.09B |
| Net Income | $8.74B |
| Gross Margin | 69.52% |
23 analysts cover AMGN: 0 strong buy, 10 buy, 11 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $396.29.